Radiomics of lung cancer (RAIL): non-invasive stratification of tumour heterogeneity for personalised cancer therapy

Informazioni relative al progetto

RAIL

ID dell’accordo di sovvenzione: 673780

DOI

10.3030/673780

Progetto chiuso

Data della firma CE 28 Maggio 2015

Data di avvio 1 Giugno 2015

Data di completamento 31 Marzo 2020

Finanziato da

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Costo totale

€ 2 427 593,75

Contributo UE

€ 2 427 593,75

Coordinato da

PT THERAGNOSTIC BV
Netherlands

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Demonstrators, pilots, prototypes (2)

Completion of patient accrual
CE approval

Complete CE file for self-regulation of RadioCAP in the EU

Documents, reports (9)

Annual update communication and dissemination plan
Research protocol written and distributed to all participating centres

Research protocol written and distributed to all participating centres.

Medical ethical approval of the phase II protocol in all centres

Medical ethical approval of the phase II protocol in all centres for clinical trial

Exploitation plan and annual updates

Exploitation plan and annual updates (M24,36,48)

Annual update communication and dissemination plan M36

Annual update communication and dissemination plan (M36).

Detailed communication and dissemination plan

Detailed communication and dissemination plan and annual updates

Dissemination material and updates

Dissemination material and updates (M12,24,36,48)

Annual update communication and dissemination plan M48

Annual update communication and dissemination plan (M48).

Design History File

The Design History File will be completed in parallel to the final RadioCAP prototype.

Websites, patent fillings, videos etc. (1)

Online version of public web site

Pubblicazioni

Peer reviewed articles (6)

Exploratory Study to Identify Radiomics Classifiers for Lung Cancer Histology

Autori: Weimiao Wu, Chintan Parmar, Patrick Grossmann, John Quackenbush, Philippe Lambin, Johan Bussink, Raymond Mak, Hugo J. W. L. Aerts
Pubblicato in: Frontiers in Oncology, Numero 6, 2016, ISSN 2234-943X
Editore: Frontiers Media S. A.
DOI: 10.3389/fonc.2016.00071

Decision support systems for personalized and participative radiation oncology

Autori: Philippe Lambin, Jaap Zindler, Ben G.L. Vanneste, Lien Van De Voorde, Daniëlle Eekers, Inge Compter, Kranthi Marella Panth, Jurgen Peerlings, Ruben T.H.M. Larue, Timo M. Deist, Arthur Jochems, Tim Lustberg, Johan van Soest, Evelyn E.C. de Jong, Aniek J.G. Even, Bart Reymen, Nicolle Rekers, Marike van Gisbergen, Erik Roelofs, Sara Carvalho, Ralph T.H. Leijenaar, Catharina M.L. Zegers, Maria Jacobs
Pubblicato in: Advanced Drug Delivery Reviews, 2016, ISSN 0169-409X
Editore: Elsevier BV
DOI: 10.1016/j.addr.2016.01.006

Prognostic value of blood-biomarkers related to hypoxia, inflammation, immune response and tumour load in non-small cell lung cancer – A survival model with external validation

Autori: Sara Carvalho, Esther G.C. Troost, Judith Bons, Paul Menheere, Philippe Lambin, Cary Oberije
Pubblicato in: Radiotherapy and Oncology, Numero 119/3, 2016, Pagina/e 487-494, ISSN 0167-8140
Editore: Elsevier BV
DOI: 10.1016/j.radonc.2016.04.024

Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer

Autori: Chintan Parmar, Patrick Grossmann, Derek Rietveld, Michelle M. Rietbergen, Philippe Lambin, Hugo J. W. L. Aerts
Pubblicato in: Frontiers in Oncology, Numero 5, 2015, ISSN 2234-943X
Editore: Frontiers Media S. A.
DOI: 10.3389/fonc.2015.00272

The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis

Autori: Ralph T.H. Leijenaar, Georgi Nalbantov, Sara Carvalho, Wouter J.C. van Elmpt, Esther G.C. Troost, Ronald Boellaard, Hugo J.W.L Aerts, Robert J. Gillies, Philippe Lambin
Pubblicato in: Scientific Reports, Numero 5, 2015, Pagina/e 11075, ISSN 2045-2322
Editore: Nature Publishing Group
DOI: 10.1038/srep11075

Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer

Autori: Evelyn E.C. de Jong, Wouter van Elmpt, Stefania Rizzo, Anna Colarieti, Gianluca Spitaleri, Ralph T.H. Leijenaar, Arthur Jochems, Lizza E.L. Hendriks, Esther G.C. Troost, Bart Reymen, Anne-Marie C. Dingemans, Philippe Lambin
Pubblicato in: Lung Cancer, Numero 124, 2018, Pagina/e 6-11, ISSN 0169-5002
Editore: Elsevier BV
DOI: 10.1016/j.lungcan.2018.07.023

Conference proceedings (1)

Prospective Validation of a Radiomics Signature for Chemoradiotherapy Lung Cancer Patients

Autori: Ralph Leijenaar, Sean Walsh
Pubblicato in: ESTRO2020, 2020
Editore: ESTRO